Is it HF secondary to rheumatic heart disease???

Similar documents
Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy: The Good, the Bad.and the Insurable?

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

HEART FAILURE. Study day November 2018 Sarah Briggs

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Management Strategies for Advanced Heart Failure

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Sudden cardiac death: Primary and secondary prevention

Heart Failure. Dr. William Vosik. January, 2012

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

Peripartum cardiomyopathy: review and practice guidelines. Hanan ALBackr Associate Professor King Saud university, King Fahad Cardaic center -Riyadh

Heart Failure Overview. Dr Chris K Y Wong

CMC Certification Review Course: Handout. Session #: 2 Congestive Heart Failure Cardiomyopathy

Cor pulmonale. Dr hamid reza javadi

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Restrictive Cardiomyopathy in Cats (a Type of Heart-Muscle Disease) Basics

Definition of Congestive Heart Failure

Innovation therapy in Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

5 Important Things to Know About Heart Failure. Kia Afshar, MD

Congestive Heart Failure or Heart Failure

Valvular Heart Disease

Assessment and Diagnosis of Heart Failure

Valvular Heart Disease. Dr. HANAN ALBACKR

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT

cardiomyopathy. INTRODUCTION NONISCHEMIC CARDIOMYOPATHY

7. Echocardiography Appropriate Use Criteria (by Indication)

CASE PRESENTATION. By: Sarah Khalil Zeina Shamil Supervised By: DR.ABDULHAK AL_NUAIMI

What s new in Hypertrophic Cardiomyopathy?

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

XVth Balkan Congress of Radiology Danubius Hotel Helia, October 2017, Budapest, Hungary

Acute Pulmonary edema Secondary to CARDIAC FAILURE NON COMPACTED LEFT VENTRICLE in Pregnancy

Cardiac Pathology & Rehabilitation

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Surgery and device intervention for the elderly with heart failure: assessing the need. Devices and Technology for heart failure in 2011

Cardiac Sarcoidosis. Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar

Heart Failure Overview. Dr Chris K Y Wong

Treatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

Cardiomyopathy Consequences. function of the myocardium for any reason. This is a serious disease in which the heart muscle

HYPERTROPHIC CARDIOMYOPATHY

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

Susan P. D Anna MSN, APRN BC February 14, 2019

Improving Transition of Care in Congestive Heart Failure. Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Topic Page: congestive heart failure

Recommended Evaluation Data Excerpt from NVIC 04-08

If you woke up breathing this morning, Congratulations! You get another chance. Use it wisely!

Valvular Heart Disease Mitral Stenosis

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

10/16/2014. CCRN Review - Cardiovascular. CCRN Review - Cardiovascular. CCRN Review - Cardiovascular

MITRAL REGURGITATION REFERRAL TOOLKIT

Understanding the guidelines for Interventions in MR. Ali AlMasood

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

CAPTIVATE SUMMARY CLINICAL SUMMARY. CAPTure Information Via Automatic Threshold Evaluation

THE CARDIOVASCULAR SYSTEM

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company

Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure

CCRN Review Cardiovascular

Cardiac MRI: Cardiomyopathy

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Clinical history. 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Cardiac catheterization: no CAD

3/17/2014. WS # 3 ICD Registry Case Scenarios with Structural Abnormalities. Objectives. Denise Pond BSN, RN

ASE 2011 Appropriate Use Criteria for Echocardiography

CLINICAL PRACTICE GUIDELINE

The ABCs of EKGs/ECGs for HCPs. Al Heuer, PhD, MBA, RRT, RPFT Professor, Rutgers School of Health Related Professions

Pathophysiology: Heart Failure

Pulmonary Hypertension: Another Use for Viagra

Carol s View of a Cardiologist

HFpEF. April 26, 2018

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

3.1 Name of the Source of Registration (OPD/ICU/Ward Name) Hospital Registration Number OPD Number...

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

The Heart Is A Muscle Too! The Cardiomyopathy In Duchenne Muscular Dystrophy

Risk of Subsequent Pregnancy in Women with a History of Peripartum Cardiomyopathy Uri Elkayam, MD

Valvular heart disease : Role of medication ( drug and intervention ) Pol.Col.Dr.Kasem Ratanasumawong

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

ECG Workshop. Nezar Amir

More History. Organization. Maternal Cardiac Disease: a historical perspective. The Parturient with Cardiac Disease 9/21/2012

Transcription:

Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF???

Cardiomyopathy

Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle 2006 AHA defined cardiomyopathies as a heterogeneous group of diseases of the myocardium associated with mechanical &/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and due to a variety of causes that frequently are genetic. Cardiomyopathies either are confined to the heart or are a part of generalized systemic disorders, often leading to cardiovascular death or progressive heart failure-related disability.

Cardiomyopathy

Functional Classification Dilated (Congestive, DCM, IDC) Ventricular dilation, hypokinetic left ventricle, and systolic dysfunction Hypertrophic Inappropriate myocardial hypertrophy, with or without left ventricular obstruction Restrictive (Infiltrative) Abnormal ventricular filling with diastolic dysfunction Arrhthymogenic Right Ventricular Fibroadipose replacement of right ventricle

Definition Primary (idiopathic) is a disease of unknown etiology that principally affects the myocardium leading to LV dilation and systolic dysfunction. Secondary causes include ischemia, alcoholic, peripartum, post-infectious, viral. Most common of the cardiomyopathies.

Schematic of Dilated CM Medslides.com

DCM - Incidence and Prognosis Prevalence is 36 per 100,000 population Highest Third most incidence common in middle cause of age heart failure Most - Blacks 2x frequent more frequent cause than whites of heart transplantation - Men 3x more frequent than women DCM accounts for approximately 10,000 deaths and 46,000 hospitalizations per year in the US Complete recovery is rare

Idiopathic Dilated Cardiomyopathy 120 Observed Survival of 104 Patients 100 104 80 60 40 20 72 56 51 45 37 35 31 24 19 16 0 Am J Cardiol 1981; 47:525 0 1 2 3 4 5 6 7 8 9 10 Years

Clinical Manifestations Symptoms may be gradual in onset Acute presentation Misdiagnosed as viral URI in young adults Uncommon to find specific myocardial disease on endomyocardial biopsy

Clinical Manifestations cont. Symptoms/Signs of heart failure Pulmonary congestion (left heart failure) dyspnea (rest, exertional, nocturnal), orthopnea Systemic congestion (right heart failure) edema, nausea, abdominal pain, nocturia - Fatigue,weakness, palpitation - Syncope or pre syncope -Sudden death

PHYSICAL FINDING

Tachycardia,tachypnea,JVP may be elevated Pulmonary rales Laterally displased and difuse point of maximal impulse,left and right ventricular lift S3 ands4 gallop Hepatomegaly due to elevated venous pressures; the liver may be pulsatile with severe tricuspid regurge. Ascites, peripheral edema Muscle wasting or other sign of cardiac cachexia

Diagnosis

Lab investigation Diagnosis Electrolyte,BUN,creatinine CBC LFT Cardiac enzymes : to exclude acute or recent myocardial inj. Thyroid function test

Diagnosis CXR (enlarged heart, CHF) Echocardiogram (left ventricular dilation, global hypokinesis, low EF,variable Electrocardiogram (tachycardia, A-V degree block, LBBB, of mitral NSSTT and changes, /or PVC s) tricuspid regurgitation) 24-hour Holter monitor Myocardial biopsy, rare If lightheadedness, palpitation, syncope Cardiac catheterization if age >40, ischemic history, high risk profile, abnormal ECG

Diagnosis Investigation to exclude CT disease Family screen

DCM - Treatment Limited activity according to patient status. Salt restriction Fluid restriction Initiate medical therapy ACE inhibitors,arbs Diuretics, digoxin for symptomatic relief Beta blockers Anticoagulation prn (EF <30%, hx of embolic events) Implantable defibrillators

DMC Treatment THERAPUTIC PROCEDURES : Implantable cardioverter-defebrilator Cardiac resynochronization therapy in patient meet criteria. WHAT IS THE CRITERIA FOR CRT??? -Patient with NYHA classiii IV symptoms and intra ventricular conduction delay -patient with left ventriculare EJ 35% despite optimal treatment -LBBB with QRS>130ms

DCM Treatment Cont. Cardiac transplantation This disorder is the most common indication for cardiac transplantation Survival after transplant is 80% one year 70% 5 years Left Ventricular Reduction Procedures LV-reshaping

When to hospitalize???? Decompinsated HF AF with rapid ventriculare response Syncope Cardiac arrest HOSPITAL DISCARGE CRITERIA After medical stabilization and optimizing HF medication After successful cardiac defibrilator and/or biventriculare pace maker device.

FOLLOW UP Every 3 months or more depend onseverity of disease Appropriate follow up with an Electrophysiologist as needed Serial ECHO

COMPLICATION s Progressive heart failure Arrhythmias Sudden death Complication of device implantation: Perforation with myocardial rupture and cardiac tamponade,infection, and bleeding.

Myocarditis Its an inflammatory disease of the cardiac muscle. Can be focal or diffuse involve endocardium\pericardium \vavular structures Most commenly associated with viral infection but could be due to infectious disease \drugs\autoimmune

Symptoms Usually variable Most commonly asymptomatic Other present with: 1-chest pain 2-dysnea\fatigue\decrease exercise tolerance 3-palpitation\dizzy \syncope 4-Cardiogenic shock

Signs Variable finding: 1-tachycardia 2-hypotention 3-fever 4-signs of fluid over load 5-murmer of mitral or tricuspid regurge

ESSENTIALS FOR DIAGNOSIS New onset heart failure preceded by viral infection. Elevated ESR with acute myocarditis ECG and ECHO may show wide variety of changes Mural thrombi may be found Endomyocardial biopsy is the gold standered for diagnosis

Mosul College of Medicine 2013